Viveve Medical Inc (NASDAQ:VIVE) announced its quarterly earnings data on Thursday. The company reported ($0.46) earnings per share for the quarter, topping the consensus estimate of ($0.48) by $0.02. The firm earned $1.85 million during the quarter, compared to analysts’ expectations of $1.70 million.

Viveve Medical (NASDAQ:VIVE) opened at 5.56 on Monday. Viveve Medical has a 12-month low of $4.02 and a 12-month high of $10.50. The firm’s 50-day moving average price is $6.26 and its 200-day moving average price is $6.50.

Several equities research analysts recently weighed in on VIVE shares. Ladenburg Thalmann started coverage on Viveve Medical in a report on Tuesday, September 20th. They issued a “buy” rating and a $22.00 price objective for the company. B. Riley assumed coverage on Viveve Medical in a report on Monday, November 7th. They issued a “buy” rating and a $8.00 price objective for the company.

About Viveve Medical

Viveve Medical, Inc, formerly PLC Systems, Inc, designs, develops, manufactures and markets medical devices for the non-invasive treatment of vaginal laxity. The Company’s Viveve Treatment is a non-invasive solution for vaginal laxity that is performed in approximately 30 minutes, in a physician’s office.

5 Day Chart for NASDAQ:VIVE

Receive News & Stock Ratings for Viveve Medical Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viveve Medical Inc and related stocks with our FREE daily email newsletter.